TBPN

← Full issue

September 2, 2026

RoninRx pitches personalized GLP-1 drugs in a viral-style ad

RoninRx founder Lloyd Armbrust says the company manufactures and personalizes GLP-1 drugs for $78 a month, including drugs like Ozempic. The advertisement says every prescription comes from a doctor and that RoninRx collects health data and uses AI to help personalize treatment.

The video describes itself as a shot-for-shot remake, while the broader format is associated with startup ads designed to go viral, including Dollar Shave Club-related work by Harmon Brothers. The format was described as having gone out of style but possibly returning because it conveys a lot of information succinctly.

The available material does not establish the quality, regulatory status, or clinical equivalence of RoninRx’s drugs. It is also unclear whether the specific video was produced using the same approach or merely styled after it.

Privacy ·